NOVEL BIOMARKER FOR PREDICTING ALLERGIC MARCH AND USE THEREOF

摘要

The present invention provides a novel biomarker for allergic march and a use thereof. As a marker of the present invention, zinc-alpha 2 glycoprotein (ZAG) show the reduced expression in the blood of patients having allergic asthma or rhinitis, accompanied by atopic dermatitis, and a complement component 3 (C3) show the increased expression, in the blood of patients having allergic asthma or rhinitis, accompanied by atopic dermatitis, compared to normal people. By early prediction of the allergic match using the marker of the present invention, proper prevention, treatment, and management of allergic diseases for each life cycle are possible.;COPYRIGHT KIPO 2017